(CIDRAP News) Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.
(CIDRAP News) – As state public health laboratories tackle their novel H1N1 influenza (swine flu) testing backlogs, the Centers for Disease Control and Prevention (CDC) said yesterday it expects to see rising case numbers across the nation along with cutbacks in the number of samples tested by states.
(CIDRAP News) With the second wave of the H1N1 influenza virus now hitting, much of the response toe the pandemic is focused on the development and distribution of an effective vaccine, a project that poses many challenges and uncertainties.
(CIDRAP News) –Many states and some cities will receive their first pandemic H1N1 vaccine doses on Oct 6, and most will distribute the first doses to healthcare workers, though some have included young children in the very first groups to be immunized.
(CIDRAP News) In a move designed to lighten the burden on emergency departments and clinics, Minnesota officials today unveiled a flu triage line staffed by nurses who can discuss symptoms with sick patients, suggest treatment steps, and prescribe an antiviral drug if the caller is in a high-risk category.
(CIDRAP News) Though only available for emergency use, intravenous (IV) antivirals peramivir and zanamivir have been lifesaving for some pandemic H1N1 patients, including two dramatic cases that doctors presented yesterday during a US Centers for Disease Control and Prevention (CDC) conference call for clinicians.
(CIDRAP News) Leaders of the US Senate Homeland Security Committee sharply critiqued the federal government's H1N1 vaccination strategy yesterday, saying health officials should have recommended targeting only the highest-risk groups as soon as the vaccine delays came to light.
(CIDRAP News) In a worrisome but not unexpected pandemic-related development, the US Centers for Disease Control and Prevention (CDC) said today that it is seeing a spike in serious pneumococcal disease, particularly in younger patients.